Clinical Trial Update: Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia [Phase 2]

View source ↗

Summary

A Phase 2 trial update on using zileuton to prevent lung cancer in patients with bronchial dysplasia. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Lung Cancer

Drugs mentioned

• ZYFLO (ZILEUTON)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Head and Neck Cancer, Lung Cancer | Phase 2 | Status: COMPLETED